Medications
Semaglutide, Wegovy, Zepbound, tirzepatide, Phentermine
Monthly Cost
$99 – $167
Speed to Start
Fast
Est. 2022
About Tmates
Tmates has been operating since 2022 and offers one of the broadest medication menus we have encountered, including both brand-name options like Wegovy and Zepbound as well as compounded semaglutide, tirzepatide, and phentermine. What immediately stands out is the pricing: at $99 to $167 per month, Tmates is among the most affordable providers in the GLP-1 telehealth space, particularly impressive given its inclusion of brand-name medications. The platform also accepts insurance, which could significantly reduce costs for eligible patients.
From a support perspective, Tmates distinguishes itself with high ongoing support — a rating we do not assign lightly in our reviews. This means patients can expect consistent check-ins, accessible customer service, and a more hands-on experience than the typical “prescribe and forget” telehealth model. The platform also holds a B+ rating with the Better Business Bureau, indicating a generally positive track record with consumer complaints and business practices. This level of accreditation adds a layer of accountability that many competitors lack.
The inclusion of phentermine alongside GLP-1 medications is an unusual offering that broadens Tmates’ appeal. Phentermine is an older, well-established weight loss medication that works through a different mechanism than GLP-1 receptor agonists, and some patients may benefit from this alternative or even a combination approach under medical supervision. Having multiple medication pathways available through a single provider simplifies the treatment journey for patients who may need to adjust their protocol.
The main weakness in Tmates’ profile is its extremely limited review history. The platform’s Trustpilot page shows a 3.2 rating based on just 1 review, which provides essentially no useful data about the broader patient experience. While the BBB rating partially compensates for this gap, prospective patients should be aware that independent patient feedback is virtually nonexistent. The platform also does not offer lab testing or dietitian access, which keeps it from reaching the top tier of clinical comprehensiveness.
Despite the thin review history, Tmates presents a compelling package on paper: affordable pricing, insurance acceptance, a wide medication selection including brand-name options, strong ongoing support, and BBB accreditation. If the platform can build a more substantial body of patient reviews over time, it has the potential to move up in our rankings. For now, it earns a solid mid-range score that reflects genuine promise tempered by the need for more external validation.
Tmates GLP-1 Medications
At a Glance
Medications Offered
Semaglutide, Wegovy, Zepbound, tirzepatide, Phentermine
Both
Cost & Insurance
- Monthly: $99 – $167
- 6-month estimate: $600 – $1002
- Insurance: Yes
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Verified Pharmacy: Not disclosed
- BBB Rating: B+
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
What the Tmates Intake Looks Like
We walked through Tmates’ full GLP-1 intake ourselves, from the welcome screen through four sequential safety multi-selects to the no-account-required final checkout. Here’s what an actual prospective patient encounters before being prescribed.
/ 10
One of the strongest compounded-provider intakes in the catalog. Four sequential safety multi-selects with rare granularity (cancer 5-year remission threshold, QT prolongation, HIV, low sodium, brain tumor), a dedicated opiate / substance use screen, BP and HR range checks, MTC + MEN2 family history called out by name, and a suicidal-thoughts checkbox. Knocked down by no validated PHQ instrument, no dedicated eating-disorder screen, no general allergy follow-up beyond Yes/No, and no medication list.
/ 10
Notably low. No early email gate, no mid-flow account creation, no ID upload, and no phone OTP. Name, email, and phone are collected only on the very last screen before “Proceed to Checkout” — meaning a prospective patient can complete the entire clinical questionnaire and see their plan options anonymously.
The 10 Stages
Clinical Safety Screens Performed
The intake doesn’t use a validated PHQ-2 or PHQ-9 depression screen — suicidal thoughts and depression are checkboxes in the safety multi-selects. There is no dedicated eating-disorder screen with severity grading (anorexia / bulimia were not visible in our walkthrough). The allergy capture is a single Yes/No on “allergic to any medications” with no follow-up list for food, dyes, supplements, or specific drugs. Current medications are a Yes/No only — no medication list is collected. There is no diet or exercise history beyond a Yes/No on prior weight-management programs (Jenny Craig, WW). Sex is collected as a binary Male / Female only.
Tmates is the only compounded GLP-1 provider in our catalog so far that lets a prospective patient complete the entire 24-screen clinical questionnaire — including all four safety multi-selects, BP and HR ranges, and the eligibility reveal — without entering an email, phone number, or creating an account. Contact information is collected on the very last screen right before “Proceed to Checkout.” For comparison, providers like Yucca Health drop an email gate at pre-qualification, and Strut Health requires email + phone (or Google SSO) before any clinical question. The trade-off: there’s no progress-saving link emailed to the patient mid-flow, so an interrupted session means starting over.
Source: GLP-1.Reviews editorial walkthrough on April 30, 2026. We completed every screen of the Tmates weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens tmates.com in a new tab.
Start your GLP-1 weight loss journey with Tmates today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
